AOU San Giovanni di Dio e Ruggi d'Aragona
Salerno, Campani, 84131, Italy
NCT Number: NCT07273669
The goal of this clinical trial is to evaluate whether LOLE.K, a new and specialized robotic bed, is effective in the rehabilitation of patients who have undergone surgery. The primary objectives of the trial are:
* Efficacy of LOLE.K: Does the LOLE.K robotic bed improve early rehabilitation in patients who undergone cardiac surgery? * Impact on recovery: Does LOLE.K influence wound healing, muscle and neurological recovery, and psychological well-being?
To address these questions, the researchers will compare the use of LOLE.K with standard physical therapy to determine whether the robotic bed results in better outcomes in post-operative rehabilitation.
This study is active but is not currently recruiting participants.
Notify Me60 year–85 year
All sexes
Interventional
Not applicable
Salerno, Campani, 84131, Italy
The goal of this clinical trial is to learn whether LOLE.K, a new and specialized robotic bed, works for rehabilitation of patients following surgery.
The main research questions are:
Researchers will compare LOLE.K bed to the usual therapy to see if LOLE.K woks better than standard post-operation rehabilitation.
Study Sites: University of Salerno Hospital and IRCCS Ospedale Galeazzi-Sant'Ambrogio.
Devices: LOLE.K robotic beds and echography machines.
Standardized protocols for sedation and analgesia management will be applied, including the Richmond Agitation-Sedation Scale (RASS) for sedation and the Behavioral Pain Scale (BPS) or Critical Pain Observation Tool (CPOT) for pain. Also, delirium will be assessed using the Confusion Assessment Method for ICU (CAM-ICU). These parametres are critical: if patients are overly sedated or inadequately anesthetized, the results on mobilization could be confounded by these factors. Assessment of delirium is important because early mobilization could also have beneficial effects on cognitive status.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Restrictions due to the device were height outside the ranfe of 190cm, weight outside the range of 115kg, pacemakers, other electrical stimulators, or implanted medical pumps.
use of the robotic bed LOLE.K for the early rehabilitation
Time frame: 12 months
The autors proposal aims to reducing the ICU and Hospital stay in cardiac surgery patients through mobilization and postural drainage. The authors aim to discharge patients from the ICU within two days of surgery and discharge them from the hospital within two weeks.
Therefore, the unit of measurement is expressed in the number of days elapsed from admission to discharge, both from the intensive care unit and from the hospital overall.
Time frame: 12 months
One of the primary objectives of this study is to achieve a reduction in the duration of mechanical ventilation compatibly with each patient's specific preoperative and postoperative conditions. In addition to the invasive ventilation phase (ventilator), a reduction in the use of non-invasive ventilation (NIV) is also sought during the immediate postoperative period, up to seven days after surgery.
The unite of measurement is the number of days the patient requires non-invasive ventilation following extubation.
Time frame: Maximum 12 months for the entire study, from enrollment to 6 months after discharge
To assess physical functioning and the associated return to usual activities, the 36-Item Short Form Health Survey version 2 (SF-36 v2) , will be administered 12 weeks after surgery. This questionnaire measures a wide range of symptoms, experiences, and health outcomes across eight domains comprising thirty-six items, addressing gaps in the assessment of patient-reported outcomes throughout the care continuum.
The unit of measurement is the SF-36 domain score (0-100).
Time frame: Maximum 12 months for the entire study, from enrollment to 6 months after discharge
To characterize patient satisfaction, we will record pain, anxiety, and satisfaction levels during mobilization, all assessed using the Numeric Rating Scale (NRS, 0-10), where 0 indicates no pain and 10 represents the worst pain imaginable. Therefore, the unit of measurement is expressed in points on a 0-10 scale.
Time frame: Maximum 12 months for the entire study, from enrollment to 6 months after discharge
Verify the benefits for muscle recovery with the multifunctional bed in patients undergoing cardiac surgery. The authors intend to demonstrate that the bed's special features promote muscle healing process thanks to the programming of cyclical postural transitions specific to cardiac surgery patients. The strength recovery is measured using a dynamometer for Lower limb and Handgrip-Test, evaluating the variation from T0 to T4.
The unite of measurement for this outcome is Kilogram (Kg).
Time frame: Maximum 12 months for the entire study, from enrollment to 6 months after discharge
To assess Neurological and psychological well-being the authors employ 36-Item Short Form Health Survey version 2 (SF-36 v2) 12 weeks after surgery. This questionnaire measures a wide range of symptoms, experiences, and health outcomes across eight domains comprising thirty-six items, addressing gaps in the assessment of patient-reported outcomes throughout the care continuum.
The unit of measurement is the SF-36 domain score (0-100).
Time frame: 12 months
One of the objectives of this study is to demonstrate the effectiveness of the LOLE.K bed in wound healing. Through early mobilization of the patient using the cyclical postural changes provided by the multifunctional robotic bed.
To define the degree of superficial or deep wound infection is used a clinical scoring system (from 0 to 12 points).
University of Salerno
Other
Acronym: CARE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07715279
AORTIC VALVE DISEASES, Aortic Valve Disease
View Trial DetailsNCT04258488
AORTIC VALVE DISEASES, Aortic Valve Disease
Bucheon-si, South Korea
View Trial DetailsNCT06830499
AORTIC VALVE DISEASES, Aortic Valve Disease
Xi'an, Shaanxi, China
View Trial DetailsNCT07379294
AORTIC VALVE DISEASES, Acute Aortic Syndrome
View Trial Details